Hopital Bretonneau; Hematologie Therapie Cellulaire
About Hopital Bretonneau; Hematologie Therapie Cellulaire
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Hopital Bretonneau; Hematologie Therapie Cellulaire
During the past decade, Hopital Bretonneau; Hematologie Therapie Cellulaire conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
2004-02-01
2012-11-01
Completed
3,397
Ixabepilone in Treating Patients With Metastatic Prostate Cancer
2004-09-01
2011-02-01
Completed
124
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
2006-01-01
2014-11-01
Completed
1,145
Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
2006-02-01
2010-08-01
Terminated
402
A Study of Talimogene Laherparepvec in Stage IIIc and Stage IV Malignant Melanoma
2005-12-01
2009-05-01
Completed
50
Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer
2006-02-17
2019-02-11
Terminated
355
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Bretonneau; Hematologie Therapie Cellulaire"
#1 collaborator was "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Hopital Bretonneau; Hematologie Therapie Cellulaire
According to Clinical.Site data, the most researched conditions in "Hopital Bretonneau; Hematologie Therapie Cellulaire" are
"Multiple Myeloma" (2 trials), "Myelodysplastic Syndromes" (2 trials), "B-cell Lymphoma" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Chronic Lymphocytic Leukemia (CLL)" (1 trials). Many other conditions were trialed in "Hopital Bretonneau; Hematologie Therapie Cellulaire" in a lesser frequency.
Clinical Trials Intervention Types at Hopital Bretonneau; Hematologie Therapie Cellulaire
Most popular intervention types in "Hopital Bretonneau; Hematologie Therapie Cellulaire" are "Drug" (9 trials). Other intervention types were less common.
The name of intervention was led by "Cyclophosphamide" (3 trials), "Rituximab" (3 trials), "Bendamustine" (2 trials), "Fludarabine" (2 trials) and "Obinutuzumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Hopital Bretonneau; Hematologie Therapie Cellulaire
The vast majority of trials in "Hopital Bretonneau; Hematologie Therapie Cellulaire" are
9 trials for "All" genders.
Clinical Trials Status at Hopital Bretonneau; Hematologie Therapie Cellulaire
Currently, there are NaN active trials in "Hopital Bretonneau; Hematologie Therapie Cellulaire".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Hopital Bretonneau; Hematologie Therapie Cellulaire,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Hopital Bretonneau; Hematologie Therapie Cellulaire, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".